EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction–Associated Steatotic Liver Disease

Meng-Lun Hsieh iD, Tung-Hung Su, Ying-Cheng Lin, Yen-Yang Chen, Chun-Fang Tung, Ling-Sung Huang, Cheng-Hao Wu, Yen-Chun Peng, Vivian Chia-Rong Hsieh iD

Journal of Gastroenterology and Hepatology · 2026-03 · 41 (3) · 1041-1051

DOI: 10.1111/jgh.70259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 09.02.2026. Verfasst von Meng-Lun Hsieh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Diet, Mediterranean, Liver Cirrhosis, Fatty Liver, Patient Compliance. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council, Taiwan, China Medical University, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims Benefits of the Mediterranean diet (MD) in reducing hepatic steatosis among individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) have been well established. This study aims to evaluate the relationship between MD adherence and liver fibrosis among the MASLD population.

Methods

This cross‐sectional study analyzed data from the National Health and Nutrition Examination Survey 2017 to March 2020. Individuals with MASLD were identified based on the vibration‐controlled transient elastography–defined steatosis. Participants' MD adherence was evaluated using the alternate Mediterranean diet (aMED) score, with higher scores indicating greater adherence. Risk of significant liver fibrosis was compared between low, moderate, and high aMED groups.

Results

Of 2672 MASLD participants, 27.2%, 42.3%, and 30.6% were categorized into low, moderate, and high aMED groups, respectively. After adjusting for the number of cardiometabolic risk factors (CMRFs), physical activity, and other covariates, participants in the high aMED group were associated with a lower risk of significant liver fibrosis compared with those in the low aMED group (aMED 5–9 vs. aMED 0–2: OR = 0.662, 95% confidence interval [CI]: 0.660–0.663; p for trend < 0.0001). In the sensitivity analyses, the protective association of higher MD adherence against the risk of significant liver fibrosis weakened with higher cardiometabolic burden (aMED 5–9: aOR 0.582, 95% CI: 0.580–0.584 [4–5 CMRFs] vs. aOR 0.383, 95% CI: 0.380–0.386 [1 CMRF]).

Conclusions

In MASLD patients, higher MD adherence was associated with lower risk of significant liver fibrosis. Our findings support the recommendation of the MD as a crucial lifestyle intervention to lower the risk of liver fibrosis in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, MediterraneanLiver CirrhosisFatty LiverPatient ComplianceMetabolic DiseasesHumansFemaleCross-Sectional StudiesMaleMiddle AgedNutrition SurveysAdultRiskRisk Factors

Stichwörter der Autor:innen

Mediterranean dietNational Health and Nutrition Examination Surveyliver fibrosismetabolic dysfunction–associated steatotic liver diseasevibration‐controlled transient elastography

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Chiayi Branch, Chiayi, Taiwan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
  • School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

ORCID-Profile: Meng-Lun Hsieh, Vivian Chia-Rong Hsieh

Förderung

  • National Science and Technology Council, Taiwan
  • China Medical University
  • National Science and Technology Council

Zitieren

APA

Hsieh, M. L., Su, T. H., Lin, Y. C., Chen, Y. Y., Tung, C. F., Huang, L. S., Wu, C. H., Peng, Y. C., & Hsieh, V. C. (2026). Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction–Associated Steatotic Liver Disease. Journal of Gastroenterology and Hepatology, 41(3), 1041-1051. https://doi.org/10.1111/jgh.70259

Vancouver

Hsieh ML, Su TH, Lin YC, Chen YY, Tung CF, Huang LS, et al. Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction–Associated Steatotic Liver Disease. Journal of Gastroenterology and Hepatology. 2026;41(3):1041-1051. doi:10.1111/jgh.70259

BibTeX
@article{Hsieh2026,
  author = {Hsieh, Meng-Lun and Su, Tung-Hung and Lin, Ying-Cheng and Chen, Yen-Yang and Tung, Chun-Fang and Huang, Ling-Sung and Wu, Cheng-Hao and Peng, Yen-Chun and Hsieh, Vivian Chia-Rong},
  title = {Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction–Associated Steatotic Liver Disease},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {3},
  pages = {1041--1051},
  doi = {10.1111/jgh.70259}
}
Kostenlos starten →